Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-003915

President sold 30,000 shares at an average $64.42 ($1,932,594)

  • President acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-13 Exercise or conversion : show line 1 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-13 Sale : show line 2 in the form −8,115 $62.79 $509,541 6,885 D
2021-01-13 Sale : show line 3 in the form −6,885 $63.72 $438,712 0 D
2021-01-14 Exercise or conversion : show line 4 in the form +15,000 $6.32 $94,800 15,000 D
2021-01-14 Sale : show line 5 in the form −12,539 $65.48 $821,054 2,461 D
2021-01-14 Sale : show line 6 in the form −2,461 $66.35 $163,287 0 D
Open-market sales · 30,000 sh · avg $64.42 · $1,932,594

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-01-13 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −15,000 260,000 D
2021-01-14 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −15,000 245,000 D
Loading xslF345X03/doc4.xml…